Observational studies and the natural history of screen-detected prostate cancer - Abstract

PURPOSE OF REVIEW: To review the recent observational studies and clinical trials that guide our understanding of the natural history of screen-detected prostate cancer.

RECENT FINDINGS: Data from observational studies and clinical trials have been updated during the past year. The most important include the Scandinavian Prostate Cancer Group 4 study and the European Randomized Study of Prostate Cancer Screening.

SUMMARY: Both retrospective population-based analyses and prospective randomized trials show that men who harbor low-volume low-grade prostate cancers have less than 6% risk of disease progression within a decade of diagnosis. For the men who pursue active surveillance prostate cancer mortality remains under 1% after a median follow-up of 6.8 years. Up to one-third of men abandon active surveillance protocols because of either prostate-specific antigen or biopsy progression. Around 10% abandon active surveillance because of anxiety. Researchers are actively exploring new imaging modalities and genetic markers to identify men whose prostate cancers are likely to progress. For now, patients with newly diagnosed prostate cancer must carefully weigh the threat posed by their disease against the possible benefits and harms associated with intervention. For some, active surveillance will be an appropriate choice.

Written by:
Albertsen PC.   Are you the author?
Department of Surgery, University of Connecticut Health Center, Farmington, Connecticut, USA.

Reference: Curr Opin Urol. 2015 Feb 16. Epub ahead of print.


PubMed Abstract
PMID: 25692723

UroToday.com Prostate Cancer Section

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe